PT2046324T - Tratamento e prevenção de mucosite por derivados de antocianidina - Google Patents

Tratamento e prevenção de mucosite por derivados de antocianidina

Info

Publication number
PT2046324T
PT2046324T PT78046554T PT07804655T PT2046324T PT 2046324 T PT2046324 T PT 2046324T PT 78046554 T PT78046554 T PT 78046554T PT 07804655 T PT07804655 T PT 07804655T PT 2046324 T PT2046324 T PT 2046324T
Authority
PT
Portugal
Prior art keywords
mucositis
prevention
treatment
anthocyanidin
derivatives
Prior art date
Application number
PT78046554T
Other languages
English (en)
Inventor
Bombardelli Ezio
Morazzoni Paolo
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37309334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2046324(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena Spa filed Critical Indena Spa
Publication of PT2046324T publication Critical patent/PT2046324T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
PT78046554T 2006-07-28 2007-07-27 Tratamento e prevenção de mucosite por derivados de antocianidina PT2046324T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06015732A EP1882473A1 (en) 2006-07-28 2006-07-28 Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs

Publications (1)

Publication Number Publication Date
PT2046324T true PT2046324T (pt) 2017-07-03

Family

ID=37309334

Family Applications (2)

Application Number Title Priority Date Filing Date
PT78046554T PT2046324T (pt) 2006-07-28 2007-07-27 Tratamento e prevenção de mucosite por derivados de antocianidina
PT121774863T PT2520295T (pt) 2006-07-28 2007-07-27 Métodos para prevenir e tratar a mucosite

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT121774863T PT2520295T (pt) 2006-07-28 2007-07-27 Métodos para prevenir e tratar a mucosite

Country Status (20)

Country Link
US (3) US20080026058A1 (pt)
EP (4) EP1882473A1 (pt)
JP (1) JP5433415B2 (pt)
KR (1) KR20090052852A (pt)
CN (1) CN101495114A (pt)
AU (1) AU2007278959B2 (pt)
BR (1) BRPI0715364A2 (pt)
CA (2) CA2935902C (pt)
DK (2) DK2046324T3 (pt)
ES (2) ES2629306T3 (pt)
HU (2) HUE031034T2 (pt)
IL (1) IL196737A (pt)
MX (1) MX2009001064A (pt)
NO (1) NO341742B1 (pt)
PL (2) PL2520295T3 (pt)
PT (2) PT2046324T (pt)
RU (1) RU2438693C2 (pt)
SG (1) SG172745A1 (pt)
SI (2) SI2520295T1 (pt)
WO (1) WO2008012666A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20042414A1 (it) * 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
ITMI20080038A1 (it) 2008-01-11 2009-07-12 Indena Spa Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva
ITMI20080395A1 (it) * 2008-03-10 2009-09-11 Indena Spa Formulazioni per il trattamento delle verruche e delle placche psoriatiche
US20110104313A1 (en) * 2008-04-24 2011-05-05 Indena S.P.A Compositions for the treatment of vaginal infections with chronic inflammation
US8496975B2 (en) * 2008-04-24 2013-07-30 Indena S.P.A. Compositions for the treatment and prevention of infections of the oral cavity
DK2133079T3 (da) * 2008-06-12 2011-12-12 Indena Spa Sammensætninger til behandling af vaginale infektioner med kronisk inflammation
ES2334746B1 (es) * 2008-07-23 2011-01-28 Feedback Trayer, S.L. Producto para la higiene intima a base de mirtillo rojo y procedimiento para su preparacion.
JP2010215532A (ja) * 2009-03-13 2010-09-30 Ands Corporation コラーゲンゲル収縮促進剤
JP2013508347A (ja) 2009-10-21 2013-03-07 マクイ ニュー ライフ ソシエダ アノニマ アントシアニジンを含む組成物及び使用方法
IT1402749B1 (it) * 2010-10-28 2013-09-18 Indena Spa Composizioni per il trattamento di ulcere periferiche di varia origine
FR2979241B1 (fr) 2011-08-30 2014-05-09 Nutrialys Medical Nutrition Sa Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
ITMI20111671A1 (it) * 2011-09-16 2013-03-17 Indena Spa Composizioni per il trattamento di ulcere periferiche di varia origine
CN104145966B (zh) * 2014-07-23 2016-09-07 中国人民解放军第二军医大学 白屈菜红碱在制备抗真菌生物被膜药物中的应用
JP6700084B2 (ja) * 2016-03-30 2020-05-27 株式会社ファンケル コーティング顆粒
JP6700083B2 (ja) * 2016-03-30 2020-05-27 株式会社ファンケル 口腔内速崩壊錠
CN106361755A (zh) * 2016-10-23 2017-02-01 徐州诺克非医药科技有限公司 含Zoarenone用于治疗溃疡性结肠炎的药物
KR20190079641A (ko) * 2016-10-27 2019-07-05 엔에스이 프로덕츠, 인크. 장 건강 촉진 조성물
CN108721276B (zh) * 2018-06-29 2020-01-07 佛山科学技术学院 一种小白菊内酯和原花青素复方药物组合物及其用途
CN109549946B (zh) * 2019-01-08 2020-12-18 牡丹江医学院 一种治疗咽炎的药物及其制备方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145412A (en) 1977-02-14 1979-03-20 Vipont Chemical Company Composition for application to oral cavity and method for preparation thereof
GB2062991B (en) * 1979-11-07 1983-11-16 Image Data Products Ltd Position co-ordinates digitiser
US4818533A (en) 1985-07-09 1989-04-04 Vipont Pharmaceutical, Inc. Production of high purity alkaloids
IT1231725B (it) * 1989-08-11 1991-12-21 Inverni Della Beffa Spa Procedimento per la preparazione di estratti ad alto contenuto in antocianosidi.
ATE123947T1 (de) 1990-07-05 1995-07-15 Indena Spa Echinacea-extrakte, verfahren zur herstellung und zubereitungen, die sie enthalten.
JP2754906B2 (ja) * 1990-11-06 1998-05-20 日本電気株式会社 半導体集積回路
US5073368A (en) * 1991-05-15 1991-12-17 Colgate-Palmolive Company Sanguinaria mouthrinse having improved anti microbial activity and stability
US5378465A (en) 1993-05-24 1995-01-03 Zeines; Victor Solution for application to an oral cavity
IT1270999B (it) * 1994-07-26 1997-05-26 Indena Spa Formulazioni a base di cumarine e loro uso in campo farmaceutico e cosmetico
NO943860D0 (no) * 1994-10-13 1994-10-13 Unifob En kjemisk forbindelse og et preparat til bruk som terapeutikum
WO1997041137A1 (en) * 1996-04-17 1997-11-06 Unifob Use of anthocyanidin and anthocyanidin derivatives
US5840322A (en) 1996-12-19 1998-11-24 Ramot-University Authority For Applied Research & Industrial Devel. Ltd. Anti-oral-microbial adhesion fraction derived from vaccinium
ITMI981542A1 (it) 1998-07-07 2000-01-07 Indena Spa Estratti di zanthoxylum bungeanum e loro formulazioni farmaceutiche e cosmetiche
US6162393A (en) 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
JP2001039844A (ja) * 1999-07-29 2001-02-13 Kikkoman Corp 咽喉用うがい剤
JP2003508415A (ja) * 1999-08-27 2003-03-04 ミシガン ステイト ユニヴァーシティー 天然シクロオキシゲナーゼ阻害剤を含有する食物サプリメント
ITMI20000628A1 (it) * 2000-03-24 2001-09-24 Indena Spa Composizioni cosmetiche ritardanti la ricrescita dei peli
AT500455B1 (de) * 2000-09-15 2007-08-15 Roth Hermann Dr Verwendung von benzophenanthridinalkaloiden als futteradditiv
EP1236466B1 (en) * 2001-02-28 2011-09-21 Axiomedic Ltd. Solid self-adhesive compositions for topical treatment of oral mucosal disorders
WO2002092028A2 (en) 2001-05-15 2002-11-21 The Procter & Gamble Company Oral care compositions
IL143318A0 (en) * 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
AU2003229923A1 (en) * 2002-04-16 2003-11-03 Isis Innovation Limited Curcumin for the prevention and/or treatment of tissue damage
US7790762B2 (en) * 2002-10-31 2010-09-07 National Jewish Health Compounds and methods for thiol-containing compound efflux and cancer treatment
GB0230042D0 (en) * 2002-12-23 2003-01-29 Britannia Pharmaceuticals Ltd Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation
FR2856304B1 (fr) * 2003-06-20 2006-03-03 Natural Product Consulting Composition pour la prevention des infections du systeme urinaire
ITMI20032287A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento delle affezioni del cavo orale e delle prime vie respiratorie
AU2005237550B2 (en) * 2004-04-28 2010-09-23 Nutrition Science Partners Limited Crude extracts from andrographis paniculata
WO2006024545A1 (en) * 2004-09-03 2006-03-09 Stichting Voor De Technische Wetenschappen Fused bicyclic natural compounds and their use as inhibitors of parp and parp-mediated inflammatory processes
ITMI20042414A1 (it) * 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
US7964223B2 (en) * 2005-09-27 2011-06-21 University Of Kentucky Research Foundation Berry preparations and extracts

Also Published As

Publication number Publication date
EP2046324A2 (en) 2009-04-15
KR20090052852A (ko) 2009-05-26
PL2520295T3 (pl) 2017-02-28
IL196737A (en) 2014-05-28
HUE031034T2 (en) 2017-06-28
NO341742B1 (no) 2018-01-15
JP5433415B2 (ja) 2014-03-05
EP2520295A1 (en) 2012-11-07
HUE031941T2 (en) 2017-08-28
SI2520295T1 (sl) 2016-11-30
CN101495114A (zh) 2009-07-29
CA2659211A1 (en) 2008-01-31
NO20090887L (no) 2009-02-26
SG172745A1 (en) 2011-07-28
EP2522345A1 (en) 2012-11-14
EP2520295B1 (en) 2016-08-17
CA2659211C (en) 2016-08-16
JP2009544687A (ja) 2009-12-17
SI2046324T1 (sl) 2017-06-30
MX2009001064A (es) 2009-02-05
AU2007278959B2 (en) 2013-03-28
AU2007278959A1 (en) 2008-01-31
IL196737A0 (en) 2009-11-18
PT2520295T (pt) 2016-11-21
CA2935902A1 (en) 2008-01-31
WO2008012666A2 (en) 2008-01-31
US20100310684A1 (en) 2010-12-09
RU2438693C2 (ru) 2012-01-10
RU2009102649A (ru) 2010-08-10
DK2046324T3 (en) 2017-06-12
US20080026058A1 (en) 2008-01-31
PL2046324T3 (pl) 2017-09-29
WO2008012666A3 (en) 2008-09-04
ES2629306T3 (es) 2017-08-08
DK2520295T3 (en) 2016-12-12
EP1882473A1 (en) 2008-01-30
US20170304341A1 (en) 2017-10-26
ES2602786T3 (es) 2017-02-22
US9730952B2 (en) 2017-08-15
BRPI0715364A2 (pt) 2013-06-18
CA2935902C (en) 2019-02-19
EP2046324B1 (en) 2017-04-05

Similar Documents

Publication Publication Date Title
PT2046324T (pt) Tratamento e prevenção de mucosite por derivados de antocianidina
HK1254895A1 (zh) 苄基苯衍生物及使用方法
ZA200900388B (en) Compositions and methods for the treatment of mucositis
IL198397A0 (en) Anilinopiperazine derivatives and methods of use thereof
EP2054063A4 (en) 4-AMINOCHINAZOLINE DERIVATIVES AND METHOD FOR THEIR USE
ZA200707472B (en) Diosmetin derivatives for the treatment and prevention of thrombotic pathologies
IL189383A0 (en) Derivatives of 4-piperazin-1-yl
PT2056675T (pt) Métodos de tratamento da mucosite oral
IL187565A0 (en) Compositions and methods for the treatment or prevention of chemoresistant neoplasia
PT2010012T (pt) Utilização de um extrato de açafrão como agente de saciedade para o tratamento do excesso de peso
IL202126A0 (en) Treatment and prevention of influenza
HUE044621T2 (hu) Vegyületek és eljárások resztenózis megelõzésére vagy kezelésére
IL196594A0 (en) Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
EP1946007A4 (en) ANDROSTERONE DERIVATIVES AND METHODS OF USE
GB2445651B (en) Well treatment products and methods of using them
EP2083848A4 (en) PROCEDURE FOR TREATMENT AND PROPHYLAXIS
EP2059235A4 (en) METHOD FOR THE PREVENTION AND TREATMENT OF ALZHEIMER DISEASE
TWI372762B (en) Amino derivatives of b-homoandrostanes and b-heteroandrostanes
EP1919472A4 (en) COMPOSITIONS AND METHODS OF TREATING AND PREVENTING HYPERURICITY-CONDITIONAL HEALTH CONSEQUENCES
IL196320A0 (en) Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
EP1951282A4 (en) TREATMENT OF HYPERSENSITIVITY
IL194798A0 (en) Treatment of melanoma
GB0808730D0 (en) Compositions and methods for the prevention and treatment of schistosomiasis
EP2331135A4 (en) METHOD FOR THE TREATMENT AND PREVENTION OF GLUCOSE TOXICITY
PL381202A1 (pl) Pochodne izochinolinowe i sposoby ich stosowania